ACOR - Acorda Therapeutics EPS beats by $0.51 beats on revenue August, 01 2019 04:02 PM Acorda Therapeutics Inc. Acorda Therapeutics (NASDAQ:ACOR): Q2 Non-GAAP EPS of -$0.55 beats by $0.51; GAAP EPS of -$0.58 beats by $0.68.More news on: Acorda Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...